Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
Providing Appropriate Opioid Prescription Quantities for Acute Pain Treatment: A Cluster Randomized Controlled Trial.
1 other identifier
interventional
205
1 country
1
Brief Summary
Prescription opioids contribute to opioid related deaths, overdose and addiction. Unused prescribed opioids are not routinely being stored or disposed of appropriately and their availability is associated with harms. Maximum daily doses prescribed are higher than that recommended in a significant number of patients. This study is designed to help have appropriate doses and quantities of opioids dispensed for the treatment of short-term pain. Rather than targeting prescribing, this study targets the dispensing process by training community pharmacists to assess the appropriateness and safety of opioid prescriptions for short-term pain and to work with patients to partially fill prescriptions if the quantities prescribed are deemed excessive. Patient education tools were developed to help promote understanding of opioid safety, including the use of appropriate quantities, safe storage and safe disposal. Pharmacists in five randomly selected regions in Ontario, Canada are targeted for the eLearning intervention. The primary study outcome is the quantities dispensed for initial opioid prescriptions for short-term pain in the intervention regions compared to ten control regions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2020
CompletedFirst Posted
Study publicly available on registry
July 23, 2020
CompletedStudy Start
First participant enrolled
September 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedJuly 20, 2022
July 1, 2022
1.5 years
July 21, 2020
July 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opioid Quantities Dispensed
Quantities dispensed for initial opioid prescriptions from all pharmacies within the 5 intervention regions for all patients without previous opioid prescriptions in the last 6 months.
6 months
Secondary Outcomes (8)
Opioid Doses Dispensed
After 6 months
Subsequent Opioid Dispensing
6 months
Opioid Quantity Changes per Pharmacy, Pharmacist and Prescriber
6 months
Prescription costs
6 months
Indication for opioid
6 months
- +3 more secondary outcomes
Study Arms (2)
Appropriate Opioid Quantities
EXPERIMENTALPharmacists in the intervention regions are invited to complete an eLearning program to promote the practice change intervention of assessing and dispensing appropriate quantities of opioids prescribed for acute pain.
Usual Practice
NO INTERVENTIONPharmacists in the comparison regions are not targeted for the practice change intervention (they are not invited nor provided access to the eLearning program).
Interventions
Pharmacist eLearning modules, support tools and resources to promote assessing and dispensing appropriate opioid quantities for acute pain.
Eligibility Criteria
You may qualify if:
- Any pharmacist working in a community pharmacy in the intervention regions.
- Any patient seeking to fill an opioid prescription for acute pain at a pharmacy in the intervention regions.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre for Addiction and Mental Healthlead
- Institute of Safe Medication Practices Canadacollaborator
- North York General Hospitalcollaborator
- The Royal Ottawa Mental Health Centrecollaborator
- Ontario Drug Policy Research Networkcollaborator
Study Sites (1)
Beth Sproule
Toronto, Ontario, M6J 1H4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beth Sproule, PharmD
Centre for Addiction and Mental Health
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2020
First Posted
July 23, 2020
Study Start
September 8, 2020
Primary Completion
February 21, 2022
Study Completion
March 31, 2022
Last Updated
July 20, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share